Rhonda L. Stanley
Plus aucun poste en cours
Profil
Rhonda L.
Stanley served as Chief Financial Officer at Asklepios BioPharmaceutical, Inc. and Chief Accounting Officer & Controller at Ocera Therapeutics, Inc. She also held the position of Vice President-Finance & Corporate Controller at Medpace Research, Inc. and Senior Vice President-Finance & Accounting at Adhera Therapeutics, Inc. Additionally, she was the Chief Financial Officer at Bamboo Therapeutics, Inc. Ms. Stanley holds an MBA from Bradley University, a graduate degree from Embry-Riddle Aeronautical University, and an undergraduate degree from Sandhills Community College.
Anciens postes connus de Rhonda L. Stanley
| Sociétés | Poste | Fin |
|---|---|---|
| ADHERA THERAPEUTICS, INC. | Directeur Financier/CFO | 07/07/2020 |
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Directeur Financier/CFO | 01/01/2018 |
Bamboo Therapeutics, Inc.
 Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | Directeur Financier/CFO | 01/05/2017 |
| NEPHROGENEX INC | Directeur Financier/CFO | 01/01/2015 |
| OCERA THERAPEUTICS INC | Directeur Financier/CFO | 25/07/2013 |
Formation de Rhonda L. Stanley
| Embry-Riddle Aeronautical University | Graduate Degree |
| Bradley University | Masters Business Admin |
| Sandhills Community College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ADHERA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Ocera Therapeutics, Inc.
 Ocera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. manufactures pharmaceuticals products. The company was founded in 2004 and is headquartered in Hazelwood, MO. | Health Technology |
Asklepios BioPharmaceutical, Inc.
Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Health Technology |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | Health Technology |
Medpace Research, Inc.
 Medpace Research, Inc. Medical DistributorsDistribution Services Medpace Research, Inc. is a pharmaceutical company, which focuses on the development of therapeutics to treat kidney disease, an area of significant unmet medical need. The company was founded by Billy G. Hudson, J. Wesley Fox Ahmann and Tryggvason Karl on May 25, 2004 and is headquartered in Cincinnati, OH. | Distribution Services |
